[1] |
Nagpal S, Lu J, Boehm MF. Vitamin D analogs: mechanism of action and therapeutic applications[J]. Curr Med Chem, 2001,8(13):1661⁃1679. doi: 10.2174/0929867013371950.
|
[2] |
Kontula K, Välimäki S, Kainulainen K, et al. Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol[J]. Br J Dermatol, 1997,136(6):977⁃978. doi: 10.1111/j.1365⁃2133. 1997.tb03955.x.
|
[3] |
Lee DY, Park BS, Choi KH, et al. Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients[J]. Arch Dermatol Res, 2002,294(1⁃2):1⁃5. doi: 10.1007/s00403⁃002⁃0293⁃3.
|
[4] |
Zhou X, Xu LD, Li YZ. The association of polymorphisms of the vitamin D receptor gene with psoriasis in the Han population of northeastern China[J]. J Dermatol Sci, 2014,73(1):63⁃66. doi: 10.1016/j.jdermsci.2013.08.014.
|
[5] |
Rucevic I, Stefanic M, Tokic S, et al. Lack of association of vitamin D receptor gene 3′⁃haplotypes with psoriasis in Croatian patients[J]. J Dermatol, 2012,39(1):58⁃62. doi: 10.1111/j.1346⁃8138.2011.01296.x.
|
[6] |
Acikbas I, Sanlı B, Tepeli E, et al. Vitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patients[J]. Med Sci Monit, 2012,18(11):CR661⁃666. doi: 10.12659/msm.883544.
|
[7] |
Polić MV, Rucević I, Barisić⁃Drusko V, et al. Polymorphisms of vitamin D receptor gene in the population of eastern Croatia with psoriasis vulgaris and diabetes mellitus[J]. Coll Antropol, 2012,36(2):451⁃457.
|
[8] |
刘军麟, 曾慧明, 林岷格, 等. 维生素D受体基因多态性与寻常性银屑病易感性及卡泊三醇疗效的相关性[J]. 中华皮肤科杂志, 2017,50(12):889⁃893. doi: 10.3760/cma.j.issn.0412⁃4030.2017.12.007.
|
[9] |
赵辨. 中国临床皮肤病学[M]. 2版. 南京: 江苏科学技术出版社, 2017.
|
[10] |
Reichrath J, Zouboulis CC, Vogt T, et al. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook[J]. Rev Endocr Metab Disord, 2016,17(3):405⁃417. doi: 10.1007/s11154⁃016⁃9353⁃4.
|
[11] |
Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice[J]. Endocr Rev, 2008,29(6):726⁃776. doi: 10.1210/er.2008⁃0004.
|
[12] |
Wang TT, Tavera⁃Mendoza LE, Laperriere D, et al. Large⁃scale in silico and microarray⁃based identification of direct 1,25⁃dihydroxyvitamin D3 target genes[J]. Mol Endocrinol, 2005,19(11):2685⁃2695. doi: 10.1210/me.2005⁃0106.
|
[13] |
Kovalenko PL, Zhang Z, Cui M, et al. 1,25 Dihydroxyvitamin D⁃mediated orchestration of anticancer, transcript⁃level effects in the immortalized, non⁃transformed prostate epithelial cell line, RWPE1[J]. BMC Genomics, 2010,11:26. doi: 10.1186/1471⁃2164⁃11⁃26.
|
[14] |
Gombart AF. The vitamin D⁃antimicrobial peptide pathway and its role in protection against infection[J]. Future Microbiol, 2009,4(9):1151⁃1165. doi: 10.2217/fmb.09.87.
|
[15] |
Verstuyf A, Carmeliet G, Bouillon R, et al. Vitamin D: a pleiotropic hormone[J]. Kidney Int, 2010,78(2):140⁃145. doi: 10.1038/ki.2010.17.
|
[16] |
Hansen CM, Binderup L, Hamberg KJ, et al. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis[J]. Front Biosci, 2001,6:D820⁃848. doi: 10.2741/hansen.
|
[17] |
Janmaat VT, Van De Winkel A, Peppelenbosch MP, et al. Vitamin D receptor polymorphisms are associated with reduced esophageal vitamin D receptor expression and reduced esophageal adenocarcinoma risk[J]. Mol Med, 2015,21:346⁃354. doi: 10.2119/molmed.2012.00336.
|
[18] |
Orlow I, Reiner AS, Thomas NE, et al. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population⁃based study[J]. Carcinogenesis, 2016,37(1):30⁃38. doi: 10.1093/carcin/bgv157.
|
[19] |
de Azevêdo Silva J, Monteiro Fernandes K, Trés Pancotto JA, et al. Vitamin D receptor (VDR) gene polymorphisms and susceptibility to systemic lupus erythematosus clinical manifestations[J]. Lupus, 2013,22(11):1110⁃1117. doi: 10.1177/ 0961203313500549.
|
[20] |
Cavalcanti CA, Silva Jde A, Pita Wde B, et al. Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis Brazilian patients[J]. Mol Biol Rep, 2016,43(1):41⁃51. doi: 10.1007/s11033⁃015⁃3937⁃z.
|
[21] |
Oh JJ, Byun SS, Lee SE, et al. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population[J]. Gene, 2014,533(1):86⁃93. doi: 10.1016/j.gene. 2013.09.119.
|
[22] |
Chang CK, Mulholland HG, Cantwell MM, et al. Vitamin D receptor gene variants and esophageal adenocarcinoma risk: a population⁃based case⁃control study[J]. J Gastrointest Cancer, 2012,43(3):512⁃517. doi: 10.1007/s12029⁃011⁃9322⁃9.
|
[23] |
Fang Y, Yu B, Yang Y, et al. Association between vitamin D receptor genetic polymorphisms and haplotypes and risk of lumbar degenerative disc disease in a Chinese population[J]. Int J Clin Exp Pathol, 2017,10(8):8695⁃8702.
|
[24] |
Vimaleswaran KS, Power C, Hyppönen E. Interaction between vitamin D receptor gene polymorphisms and 25⁃hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes[J]. Diabetes Metab, 2014,40(5):386⁃389. doi: 10. 1016/j.diabet.2014.01.003.
|
[25] |
Shen F, Guo C, Wang Y, et al. Low serum 25⁃hydroxyvitamin D levels may increase the detrimental effect of VDR variants on the risk of essential hypertension[J]. Eur J Clin Nutr, 2020,74(7):1091⁃1099. doi: 10.1038/s41430⁃019⁃0543⁃5.
|
[26] |
Yu F, Wang C, Wang L, et al. Study and evaluation the impact of vitamin D receptor variants on the risk of type 2 diabetes mellitus in Han Chinese[J]. J Diabetes, 2017,9(3):275⁃284. doi: 10.1111/1753⁃0407.12413.
|
[27] |
Karami S, Brennan P, Rosenberg PS, et al. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk[J/OL]. PLoS One, 2009,4(9):e7013. https://journals.plos.org/plosone/ article?id=10.1371/journal.pone.0007013. doi: 10.1371/journal.pone.0007013.
|
[28] |
Hu Q, Chen Z, Liang G, et al. Vitamin D receptor gene associations with pulmonary tuberculosis in a Tibetan Chinese population[J]. BMC Infect Dis, 2016,16:469. doi: 10.1186/s12879⁃016⁃1699⁃4.
|
[29] |
Kelly JL, Drake MT, Fredericksen ZS, et al. Early life sun exposure, vitamin D⁃related gene variants, and risk of non⁃Hodgkin lymphoma[J]. Cancer Causes Control, 2012,23(7):1017⁃1029. doi: 10.1007/s10552⁃012⁃9967⁃0.
|
[30] |
Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB[J]. Mol Endocrinol, 2000,14(3):401⁃420. doi: 10.1210/mend.14.3.0435.
|
[31] |
Colin EM, Weel AE, Uitterlinden AG, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25⁃dihydroxyvitamin D3[J]. Clin Endocrinol (Oxf), 2000,52(2):211⁃216. doi: 10.1046/j.1365⁃2265.2000.00909.x.
|
[32] |
Holt SK, Kwon EM, Koopmeiners JS, et al. Vitamin D pathway gene variants and prostate cancer prognosis[J]. Prostate, 2010,70(13):1448⁃1460. doi: 10.1002/pros.21180.
|
[33] |
Shi J, Grundy A, Richardson H, et al. Genetic variation in vitamin D⁃related genes and risk of breast cancer among women of European and East Asian descent[J]. Tumour Biol, 2016,37(5):6379⁃6387. doi: 10.1007/s13277⁃015⁃4417⁃8.
|
[34] |
Jingwi EY, Abbas M, Ricks⁃Santi L, et al. Vitamin D receptor genetic polymorphisms are associated with PSA level, gleason score and prostate cancer risk in African⁃American men[J]. Anticancer Research, 2015, 35(3):1549⁃1558.
|